EDITAS MEDICINE, INC. (EDIT) Free cash flow 2016–2025
EDITAS MEDICINE, INC. (EDIT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$165.8MFY2025 · since FY2016: -$53.7M → -$165.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$165.8M | +24.3% |
| FY2024 | -$219.1M | -60.1% |
| FY2023 | -$136.9M | +24.6% |
| FY2022 | -$181.5M | -5.6% |
| FY2021 | -$171.8M | +8.1% |
| FY2020 | -$187.0M | -299.3% |
| FY2019 | -$46.8M | +7.2% |
| FY2018 | -$50.5M | -339.7% |
| FY2017 | -$11.5M | +78.6% |
| FY2016 | -$53.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDIT financial trends
EDIT RevenueEDIT Net incomeEDIT Net marginEDIT Gross profitEDIT Gross marginEDIT Operating incomeEDIT Operating marginEDIT Operating cash flowEDIT Capital expendituresEDIT Return on equityEDIT Stock buybacksEDIT Dividends paidEDIT Total assetsEDIT Total liabilitiesEDIT Shareholders’ equityEDIT overview →